{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"17.95","value":"-7.87"},{"groupId":"OG001","spread":"16.77","value":"-10.91"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"86"},{"groupId":"OG001","value":"105"}],"units":"Participants"}],"description":"The EQ-5D-5L is a standardized instrument for use as a measure of self-reported health status. A unique EQ-5D health state is defined by combining 1 level from each of the 5 dimensions. Participants indicated their current health status by marking on a VAS ranging from 100 (best imaginable health state) to 0 (worst imaginable health state).","dispersionType":"Standard Deviation","groups":[{"description":"Ramucirumab (10 mg/kg) IV plus docetaxel (75 mg/m²) IV on day 1 of each 21-day cycle. Participants may continue to receive treatment until discontinuation criteria are met.","id":"OG000","title":"Ramucirumab + Docetaxel"},{"description":"Placebo IV plus docetaxel (75 mg/m²) IV ion day 1 of each 21-day cycle. Participants may continue to receive treatment until discontinuation criteria are met.","id":"OG001","title":"Placebo + Docetaxel"}],"paramType":"MEAN","populationDescription":"All randomized participants with baseline and 30-day follow-up data.","reportingStatus":"POSTED","timeFrame":"Randomization, 30 Days After Treatment Discontinuation (Up to 18 Months)","title":"Change From Baseline on the EuroQol 5-Dimension, 5-Level Questionnaire (EQ-5D-5L) Visual Analogue Scale (VAS)","type":"SECONDARY","unitOfMeasure":"millimeter (mm)"}